A porphyria kindred in which the index case has porphyria variegata had also been shown to include a case of porphyria cutanea tarda, typical both from chemical and clinical features. The possibility that this was purely acquired rather than genetic seemed unlikely, but could not be wholly excluded. Recently, a niece of both of these cases, although asymptomatic, has been found to conform chemically with porphyria cutanea tarda, including the excretion of the isocoproporphyrin series, and thus represents the second case of this form of porphyria in this family. This strengthens the concept of genetic heterogeneity in this kindred and supports the suggestion of a double heterozygosity, as proposed in the primary paper [Watson, C. J. et aL (1975) Proc. Nat. Acad.
Recently, a paper which appeared in these PROCEEDINGS (1) described an individual (P431) with chemically typical porphyria cutanea tarda (PCT), member of a porphyria family in which the index case (P430) was clearly one of porphyria variegata. Four additional members, P435, P447, P461, and P462, have clinically latent porphyria variegata, but characteristic chemical abnormalities, while 20 are negative for either porphyric trait. Of chief interest, however, is an asymptomatic female member of the kindred, age 37.
She had been repeatedly urged to submit samples for porphyrin analysis, but, until quite recently, had failed to comply. When eventually sent, however, these samples provided data of great interest, readily permitting her classification as PCT (P472). (See Table la , which also includes previously unpublished data for P461 and P462.)
P472 is of particular significance as she represents the second case of PCT in this kindred, strongly supporting the belief that both P472 and P431 are related to genetic heterogeneity, rather than an acquired or "symptomatic" abnormality. The presence of the two forms of porphyria thus demonstrated in this family is quite in accord with the postulation of a double heterozygosity.
Abbreviation: PCT, porphyria cutanea tarda. See Materials and Methods in the primary paper (1).
In the primary paper (1), the possibility was considered that a genetic error in PCT might relate to coproporphyrinogenase (coproporphyrinogen oxidase, EC 1.3.3.3) in conversion of the 5-COOH intermediate to the isocopro-series. Recently, however, the possibility is being considered that PCT may relate primarily to a partial (genetic) deficiency of the decarboxylase converting 7-to 6-COOH porphyrin, a deficiency which may be enhanced by alcohol, C6C16, or other "revealing" agents which might also relate to an acquired defect in formation of the isocopro-series.
